VTVT Earnings History image   This VTVT earnings history page last updated 5/13/2024
VTVT Earnings History Chart
PeriodEarnings DateGAAP
Q1 20245/9/2024-1.170
Q4 20233/13/2024-1.670
Q3 202311/9/2023-3.200
Q2 20238/11/2023-2.800
Q1 20235/11/2023-2.400
Q4 20223/6/2023-2.400
Q3 202211/10/2022-2.000
Q2 20228/15/2022-1.600
Q1 20225/12/2022-4.000
Q4 20213/29/2022-4.400
Q3 202111/9/2021-0.800
Q2 20218/4/2021-0.400
Q1 20215/5/2021-3.600
Q4 20202/24/20210.800
Q3 202011/5/2020-0.800
Q2 20208/3/2020-3.200
Q1 20205/7/2020-4.400
Q4 20192/20/2020-4.400
Q3 201910/30/2019-4.000
Q2 20197/31/2019-3.600
Q1 20195/1/2019-3.600
Q4 20182/27/2019-3.200
Q3 201811/8/2018-2.400
Q2 20188/3/2018-11.600
Q1 20185/15/2018-12.000
Q4 20172/27/2018-17.600
Q3 201711/1/2017-15.200
Q2 20178/2/2017-16.400
Q1 20175/3/2017-17.600
Q4 20162/27/2017-16.800
Q3 201611/3/2016-16.400
Q2 20168/2/2016-18.800
Q1 20165/12/2016-16.800
Q4 20153/1/2016-14.000
Q3 201511/12/2015-19.600
VTVT Revenue History Chart
PeriodEarnings DateGAAP
Q1 20245/9/20240.00B
Q4 20233/13/2024NA
Q3 202311/9/2023NA
Q2 20238/11/2023NA
Q1 20235/11/2023NA
Q4 20223/6/20230.01M
Q3 202211/10/2022NA
Q2 20228/15/20220.01M
Q1 20225/12/20220.00B
Q4 20213/29/20220.01M
Q3 202111/9/20210.00B
Q2 20218/4/20210.01M
Q1 20215/5/20210.00B
Q4 20202/24/20210.01B
Q3 202011/5/2020NA
Q2 20208/3/2020NA
Q1 20205/7/20200.01M
Q4 20192/20/20200.01M
Q3 201910/30/20190.01M
Q2 20197/31/20190.00B
Q1 20195/1/20190.00B
Q4 20182/27/20194.52M
Q3 201811/8/20183.38M
Q2 20188/3/20182.47M
Q1 20185/15/20182.06M
Q4 20172/27/2018233000
Q3 201711/1/201715000
Q2 20178/2/201713000
Q1 20175/3/201730000
Q4 20162/27/201738000
Q3 201611/3/201638000
Q2 20168/2/2016182000
Q1 20165/12/2016376000
Q4 20153/1/2016226000
Q3 201511/12/2015133000
Quotes delayed 20 minutes

Email EnvelopeFree VTVT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options

Next Earnings Date Calendar:

Fortrea Holdings (FTRE): 5/13/2024 6:30 AM
Precision BioSciences (DTIL): 5/13/2024 7:00 AM
Akoustis Technologies (AKTS): 5/13/2024 7:00 AM
Fulcrum Therapeutics (FULC): 5/13/2024 7:00 AM
NET Power (NPWR): 5/13/2024 7:30 AM
Verrica Pharmaceuticals (VRCA): 5/13/2024 7:30 AM
Innovative Solns (ISSC): 5/13/2024 8:00 AM
Exagen (XGN): 5/13/2024 8:00 AM
Lucid Diagnostics (LUCD): 5/13/2024 8:00 AM
Live Ventures (LIVE): 5/13/2024 8:30 AM

More from the Next Earnings Dates Calendar

Earnings History:

Fiserv (FI): 5/12/2024 12:48 PM
Siebert Finl (SIEB): 5/10/2024 5:19 PM
Moleculin Biotech (MBRX): 5/10/2024 5:10 PM
W&T Offshore (WTI): 5/10/2024 5:00 PM
Chicago Rivet & Machine (CVR): 5/10/2024 After close
Global Self Storage (SELF): 5/10/2024 After close
Seritage Growth Props (SRG): 5/10/2024 After close
Network-1 Technologies (NTIP): 5/10/2024 After close
Tandy Leather Factory (TLF): 5/10/2024 After close
Consumer Pf Servs (CPSS): 5/10/2024 After close

More from the Earnings History archive
vTv Therapeutics (VTVT) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

VTYX Past Earnings
VVOS Past Earnings
VXRT Past Earnings
VYGR Past Earnings
VYNE Past Earnings
VYNT Past Earnings
WAT Past Earnings
WGS Past Earnings
WINT Past Earnings
WST Past Earnings
On this page we presented the VTVT earnings and revenue history archive for vTv Therapeutics, comparing the historical top line revenue performance quarter by quarter, as well as the VTVT earnings per share history. Any self directed investor doing their due diligence on VTVT (or any other given stock) can benefit from researching all of the vTv Therapeutics past earnings and revenue results going backwards in time, and to help you with this vTv Therapeutics earnings history research, on this page we presented each quarter's resulting numbers in both table and graphical form for easy comparison. Studying these numbers can help an investor by providing important context with which to think about VTVT's next earnings report. In your continued research on vTv Therapeutics we hope you will be sure to check out the further links included for earnings surprises as well as next earnings dates for VTVT. Thanks for visiting, and the next time you need to research VTVT earnings history (or the earnings history of another stock), we hope you'll think of our site as your go-to earnings history research resource of choice.

Recommended: ETFs Holding AMTD, Funds Holding SUTR, Funds Holding GEB.

 

VTVT Earnings History | www.NextEarningsDate.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in NextEarningsDate.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.